# UNIVERSITY OF CALIFORNIA, SAN FRANCISCO: Validation, translation, and clinical implementation of a gene expression biomarker to predict meningioma outcomes and radiotherapy responses

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO |
| Location | SAN FRANCISCO, CA |
| Project | Validation, translation, and clinical implementation of a gene expression biomarker to predict meningioma outcomes and radiotherapy responses |
| Project number | 5UH3CA298962-02 |
| Mechanism | UH3 |
| Institute | National Cancer Institute |
| Award | $298,064 |
| Awarded | 2026-09-18 |
| Project period | 2025-09-01 to 2028-08-31 |
| UEI | KMH5K9V7S518 |

## Why this score
- Award of $298,064.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11394565). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.